Kendall Capital Management
Source: SEC Form 13F · as of Mar 2026Kendall Capital Management holds 25 biotech & pharma companies tracked by BioSniper, totaling $44.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$44.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 24,945 | $5.4M |
| CORCencora Inc. | 17,235 | $5.4M |
| BMYBRISTOL MYERS SQUIBB CO | 61,555 | $3.7M |
| UTHRUNITED THERAPEUTICS Corp | 6,281 | $3.7M |
| MCKMcKesson Corporation | 3,320 | $2.9M |
| VTRSViatris Inc | 207,623 | $2.8M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 43,766 | $2.4M |
| MRKMerck & Co., Inc. | 19,782 | $2.4M |
| JNJJOHNSON & JOHNSON | 8,136 | $2.0M |
| JAZZJazz Pharmaceuticals plc | 9,344 | $1.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,116 | $1.6M |
| LLYELI LILLY & Co | 1,419 | $1.3M |
| PFEPFIZER INC | 45,452 | $1.3M |
| GILDGILEAD SCIENCES, INC. | 8,567 | $1.2M |
| MEDPMedpace Holdings Inc. | 2,300 | $1.1M |
| AMGNAMGEN INC | 2,996 | $1.1M |
| INCYIncyte Corp. | 8,805 | $829K |
| INVAInnoviva, Inc. | 35,285 | $822K |
| AZNASTRAZENECA PLC | 3,976 | $784K |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 16,265 | $538K |
| NVSNovartis AG | 2,295 | $351K |
| CAHCardinal Health Inc. | 1,620 | $342K |
| SNYSanofi | 4,540 | $219K |
| HRMYHarmony Biosciences Holdings, Inc. | 7,695 | $216K |
| OGNOrganon & Co. | 15,228 | $91K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.